Search results
Results from the WOW.Com Content Network
Studies have shown that 5–15% of people who are 20–50 years old, 20–30% of people who are 50–70 years old, and 10–50% of people 70+ years old urinate at least twice a night. [3] Nocturia becomes more common with age. More than 50 percent of men and women over the age of 60 have been measured to have nocturia in many communities.
Since most bedwetting is simply a developmental delay, most treatment plans aim to protect or improve self-esteem. [6] Treatment guidelines recommend that the physician counsel the parents, [ 10 ] warning about psychological consequences caused by pressure, shaming, or punishment for a condition children cannot control.
Nocturia is the need of frequent urination at night. [1] The most common cause of this condition for women and children is a urinary tract infection . The most common cause of urinary frequency in older men is an enlarged prostate .
A fasting blood sugar level of ≥ 7.0 mmol / L (126 mg/dL) is used in the general diagnosis of diabetes. [17] There are no clear guidelines for the diagnosis of LADA, but the criteria often used are that the patient should develop the disease in adulthood, not need insulin treatment for the first 6 months after diagnosis and have autoantibodies in the blood.
Desmopressin is used in the treatment of central diabetes insipidus (DI) as a replacement for endogenous antidiuretic hormone (ADH) that is in insufficient quantity due to decreased or non-existent secretion or production of ADH by the posterior pituitary or hypothalamus, respectively.
The beta-3 adrenergic receptor (beta3AR) was discovered in the late 1980s [20] and initially, beta3AR agonists were investigated as treatment for obesity and diabetes. [21] A number of compounds were tested in clinical trials but didn't show sufficient benefits in these areas. [21]
Untreated central diabetes insipidus patients usually exhibit polyuria, nocturia, and polydipsia as a result of the initial rise of serum sodium and osmolality. [5] Patients may also experience neurologic symptoms associated with the underlying illness, such as headaches and diplopia, depending on the exact origin of the central diabetes insipidus.
This is a shortened version of the third chapter of the ICD-9: Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders. It covers ICD codes 240 to 279 . The full chapter can be found on pages 145 to 165 of Volume 1, which contains all (sub)categories of the ICD-9.